Director, Technology & Venture Development
As Director, Technology & Venture Development for the life sciences, Kevin develops strategies to bring medicines invented in the local scientific community to patients. He does this by assessing the unmet medical need, the standard of care, and the patient journey in relation to the business potential of an opportunity. He performs technical and market due diligence and evaluates the competitive positioning and advantages of new technologies to support and expand MaRS Innovation’s portfolio. He develops business, technical, strategic and financing plans to bring new start-up ventures to fruition. He also actively markets technologies to support licensing, co-development and other commercialization transactions.
Kevin has over fifteen years of leadership and people-management experience in roles of increasing responsibility in the pharmaceutical industry. He has worked in, and led teams in, basic research and genetics, research alliances/scouting, venture capital, clinical research, statistics, epidemiology, data management, medical development, commercial assessment, medical affairs, outsourcing and contracts, strategy and operations.
Prior to joining MaRS Innovation Kevin spent more than three years at GSK China R&D in Shanghai as Director, Strategy and Operations. In addition to leading teams and programs in China, Kevin was secretary to the Portfolio Board of GSK China, supporting the Board’s optimal decision-making in choosing which assets to develop for China and how to develop them.
Kevin holds a Ph.D. and an H.B.Sc. in Physiology, both from Western University. He holds an M.B.A. from the Ivey Business School, Western University and was recognized as an Ivey Scholar in this program.